Simultaneous multi-parametric analysis of Leishmania and of its hosting mammal cells: A high content imaging-based method enabling sound drug discovery process.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Microbial Pathogenesis

• Publication date

  2015-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.micpath.2014.10.012PMID 25448129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new, rapid and sensitive bioluminescence assay for drug screening on Leishmania.

  2013cited by this paper
• The Cell Biology of Leishmania: How to Teach Using Animations

  2013cited by this paper
• Photoconvertible pathogen labeling reveals nitric oxide control of Leishmania major infection in vivo via dampening of parasite metabolism.

  2013cited by this paper
• High Content Analysis of Primary Macrophages Hosting Proliferating Leishmania Amastigotes: Application to Anti-leishmanial Drug Discovery

  2013cited by this paper
• High-resolution molecular imaging via intravital microscopy: illuminating vascular biology in vivo.

  2013cited by this paper
• In vivo multiphoton imaging of mitochondrial structure and function during acute kidney injury.

  2013cited by this paper
• Parasite burden in Leishmania (Leishmania) amazonensis-infected mice: validation of luciferase as a quantitative tool.

  2013cited by this paper
• Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay

  2013cited by this paper
• An alternative in vitro drug screening test using Leishmania amazonensis transfected with red fluorescent protein.

  2013cited by this paper
• Animal model for cutaneous leishmaniasis.

  2013cited by this paper
• Improvement of 96-well microplate assay for estimation of cell growth and inhibition of Leishmania with Alamar Blue.

  2013cited by this paper
• Surgical implantation of an abdominal imaging window for intravital microscopy

  2013cited by this paper
• Leishmaniasis Worldwide and Global Estimates of Its Incidence

  2012cited by this paper
• Innate Immune Activation and Subversion of Mammalian Functions by Leishmania Lipophosphoglycan

  2012cited by this paper
• An Image-Based High-Content Screening Assay for Compounds Targeting Intracellular Leishmania donovani Amastigotes in Human Macrophages

  2012cited by this paper
• Appraisal of a Leishmania major Strain Stably Expressing mCherry Fluorescent Protein for Both In Vitro and In Vivo Studies of Potential Drugs and Vaccine against Cutaneous Leishmaniasis

  2012cited by this paper
• Intravital microscopy of the spleen: quantitative analysis of parasite mobility and blood flow.

  2012cited by this paper
• Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs.

  2012cited by this paper
• Visceral leishmaniasis: Experimental models for drug discovery

  2011cited by this paper
• A Screen against Leishmania Intracellular Amastigotes: Comparison to a Promastigote Screen and Identification of a Host Cell-Specific Hit

  2011cited by this paper
• Apical membrane rupture and backward bile flooding in acetaminophen-induced hepatocyte necrosis

  2011cited by this paper
• Principles of early drug discovery

  2011cited by this paper
• Structures, Targets and Recent Approaches in Anti-Leishmanial Drug Discovery and Development

  2011cited by this paper
• Luciferase-Expressing Leishmania infantum Allows the Monitoring of Amastigote Population Size, In Vivo, Ex Vivo and In Vitro

  2011cited by this paper
• Leishmaniasis: complexity at the host–pathogen interface

  2011cited by this paper
• Intravital microscopy as a tool to study drug delivery in preclinical studies.

  2011cited by this paper
• Intravital imaging.

  2011cited by this paper
• In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters

  2011cited by this paper
• Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New Scaffolds

  2010cited by this paper
• Noninvasive biophotonic imaging for studies of infectious disease

  2010cited by this paper
• In vivo imaging of transgenic Leishmania parasites in a live host.

  2010cited by this paper
• Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in tumor vascular networks

  2010cited by this paper
• iNOS-Producing Inflammatory Dendritic Cells Constitute the Major Infected Cell Type during the Chronic Leishmania major Infection Phase of C57BL/6 Resistant Mice

  2009cited by this paper
• Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening.

  2009cited by this paper
• High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric β-lactamase assay

  2009cited by this paper
• Identification of Potent Chemotypes Targeting Leishmania major Using a High-Throughput, Low-Stringency, Computationally Enhanced, Small Molecule Screen

  2009cited by this paper
• Reporter genes facilitating discovery of drugs targeting protozoan parasites.

  2009cited by this paper
• High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric beta-lactamase assay.

  2009cited by this paper
• Drug Resistance in Visceral Leishmaniasis

  2009cited by this paper
• Intravital imaging of metastatic behavior through a mammary imaging window

  2008cited by this paper
• Migratory Dermal Dendritic Cells Act as Rapid Sensors of Protozoan Parasites

  2008cited by this paper
• In Vivo Imaging Reveals an Essential Role for Neutrophils in Leishmaniasis Transmitted by Sand Flies

  2008cited by this paper
• Real-Time In Vivo Green Fluorescent Protein Imaging of a Murine Leishmaniasis Model as a New Tool for Leishmania Vaccine and Drug Discovery

  2008cited by this paper
• Intracellular parasite kill: flow cytometry and NO detection for rapid discrimination between anti-leishmanial activity and macrophage activation.

  2008cited by this paper
• Rapid fluorescent assay for screening drugs on Leishmania amastigotes.

  2008cited by this paper
• Advances and perspectives in Leishmania cell based drug-screening procedures.

  2007cited by this paper
• Drugs for bad bugs: confronting the challenges of antibacterial discovery

  2007cited by this paper
• Optimization of Topical Therapy for Leishmania major Localized Cutaneous Leishmaniasis Using a Reliable C57BL/6 Model

  2007cited by this paper
• Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

  2007cited by this paper
• New developments in diagnosis of leishmaniasis.

  2006cited by this paper
• Drug Resistance in Leishmaniasis

  2006cited by this paper
• Development of a semi-automated colorimetric assay for screening anti-leishmanial agents.

  2006cited by this paper
• Animal models for vaccine studies for visceral leishmaniasis.

  2006cited by this paper
• Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis

  2006cited by this paper
• Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.

  2006cited by this paper
• Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy.

  2005cited by this paper
• Target-based drug discovery: is something wrong?

  2005cited by this paper
• Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote‐harbouring macrophages and for quantitative real‐time monitoring of parasitism features in living mice

  2005cited by this paper
• Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

  2004cited by this paper
• Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs.

  2003cited by this paper
• Hydrosoluble formazan XTT: its application to natural products drug discovery for Leishmania.

  2003cited by this paper
• Two separate growth phases during the development of Leishmania in sand flies: implications for understanding the life cycle.

  2003cited by this paper
• Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites.

  2002cited by this paper
• Flow Cytometric Detection of LeishmaniaParasites in Human Monocyte-Derived Macrophages: Application to Antileishmanial-Drug Testing

  2000cited by this paper
• Accurate quantitation of Leishmania infection in cultured cells by flow cytometry.

  2000cited by this paper
• A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue.

  2000cited by this paper
• Fibroblasts as Host Cells in Latent Leishmaniosis

  2000cited by this paper
• Calmodulin antagonists inhibit insulin-stimulated GLUT4 (glucose transporter 4) translocation by preventing the formation of phosphatidylinositol 3,4,5-trisphosphate in 3T3L1 adipocytes.

  2000cited by this paper
• Episomal and stable expression of the luciferase reporter gene for quantifying Leishmania spp. infections in macrophages and in animal models.

  2000cited by this paper
• Comparison of different staining procedures for the flow cytometric analysis of U-937 cells infected with different Leishmania-species.

  1999cited by this paper
• An axenic amastigote system for drug screening

  1997cited by this paper
• Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes

  1997cited by this paper
• Use of an enzymatic micromethod to quantify amastigote stage of Leishmania amazonensis in vitro

  1997cited by this paper
• Identification of an infective stage of Leishmania promastigotes.

  1984cited by this paper

• Repurposing of a library for high-content screening of inhibitors against Echinococcus granulosus

  2024cites this paper
• Leishmania donovani Metacyclic Promastigotes Impair Phagosome Properties in Inflammatory Monocytes

  2021cites this paper
• Assay development in leishmaniasis drug discovery: a comprehensive review

  2021cites this paper
• Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening

  2019cites this paper
• Meta-analysis and discussion on challenges to translate Leishmania drug resistance phenotyping into the clinic.

  2019cites this paper
• Design and Application of a High-Throughput, High-Content Screening System for Natural Product Inhibitors of the Human Parasite Trichomonas vaginalis.

  2019cites this paper
• Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites

  2017cites this paper
• Development of Phenotypic Drug Discovery Models for Tropical Parasitic Diseases

  2017cites this paper
• Chemotherapy of leishmaniasis: present challenges

  2017cites this paper
• Leishmania antimony resistance/ susceptibility in Algerian foci

  2017cites this paper
• High-Content Assay for Measuring Intracellular Growth of Leishmania in Human Macrophages

  2015cites this paper
• Novel arylalkylamine compounds exhibits potent selective antiparasitic activity against Leishmania major.

  2015cites this paper